Kurma Partners 3
3 · IO Biotech, Inc. · Filed Aug 21, 2023
Insider Transaction Report
Form 3
IO Biotech, Inc.IOBT
Kurma Partners
10% Owner
Holdings
- (indirect: See Footnote)
Warrants (Right to Buy)
Exercise: $2.47From: 2023-08-09→ Common Stock (273,603 underlying) - 4,345,679(indirect: See Footnote)
Common Stock
- 1,852,026(indirect: See Footnote)
Common Stock
- 623,428(indirect: See Footnote)
Common Stock
- (indirect: See Footnote)
Warrants (Right to Buy)
Exercise: $2.47From: 2023-08-09→ Common Stock (4,345,679 underlying) - (indirect: See Footnote)
Warrants (Right to Buy)
Exercise: $2.47From: 2023-08-09→ Common Stock (812,815 underlying)
Footnotes (5)
- [F1]The securities are held by Kurma Growth Opportunities Fund FPCI. Kurma Partners is the management company of Kurma Growth Opportunities Fund FPCI.
- [F2]The securities are held by Kurma Biofund III FPCI. Kurma Partners is the management company of Kurma Biofund III FPCI.
- [F3]The securities are held by SKCI FPCI. Kurma Partners is the management company of SKCI FPCI.
- [F4]The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
- [F5]These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023).